We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$19.9B
AUM Growth
+$1.62B
Cap. Flow
-$35.6M
Cap. Flow %
-0.18%
Top 10 Hldgs %
43.73%
Holding
208
New
17
Increased
41
Reduced
35
Closed
35

Sector Composition

Rank Sector Weight
1 Healthcare 35.32%
2 Technology 16.45%
3 Financials 12.17%
4 Industrials 7.23%
5 Communication Services 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIMO icon
51
Silicon Motion
SIMO
$8.68B
$67.2M 0.34%
935,000
+230,000
+33% +$14.7M
OPCH icon
52
Option Care Health
OPCH
$3.56B
$67.2M 0.34%
+2,067,134
New +$62.3M
NTRA icon
53
Natera
NTRA
$46.1B
$64.4M 0.32%
1,324,183
+662,400
+100% +$33.8M
ARGX icon
54
argenx
ARGX
$54.1B
$62.7M 0.31%
+161,000
New +$63.3M
THC icon
55
Tenet Healthcare
THC
$21.1B
$61.2M 0.31%
752,000
+363,000
+93% +$25.8M
CI icon
56
Cigna
CI
$74.6B
$61.2M 0.31%
+218,000
New +$56.8M
MASI
57
DELISTED
Masimo
MASI
$60.5M 0.3%
367,649
-264,000
-42% -$46M
KDNY
58
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$58.5M 0.29%
+1,523,000
New +$39.1M
EVH icon
59
Evolent Health
EVH
$444M
$57.6M 0.29%
1,900,909
+757,000
+66% +$24.5M
EXAS
60
DELISTED
Exact Sciences
EXAS
$56.5M 0.28%
+602,000
New +$47M
AJRD
61
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$52.6M 0.26%
959,378
+689,378
+255% +$38.3M
RETA
62
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$46.1M 0.23%
451,700
+126,700
+39% +$12M
TSEM icon
63
Tower Semiconductor
TSEM
$28.5B
$43.5M 0.22%
1,160,000
+185,000
+19% +$7.65M
UTHR icon
64
United Therapeutics
UTHR
$23.1B
$42.7M 0.21%
193,267
-471,500
-71% -$104M
ENTA icon
65
Enanta Pharmaceuticals
ENTA
$400M
$40.1M 0.2%
1,875,000
+325,000
+21% +$9.58M
AMAM
66
DELISTED
Ambrx Biopharma Inc
AMAM
$37.3M 0.19%
2,269,000
+1,908,000
+529% +$24M
SVRA icon
67
Savara
SVRA
$1.19B
$34.9M 0.17%
10,908,086
LU icon
68
Lufax Holding
LU
$1.3B
$28.5M 0.14%
4,987,455
-4,586,681
-48% -$30.3M
ROIV icon
69
Roivant Sciences
ROIV
$26.2B
$23.7M 0.12%
+2,355,000
New +$21.1M
AEL
70
DELISTED
American Equity Investment Life Holding Company
AEL
$20M 0.1%
+383,000
New +$15.4M
AXSM icon
71
Axsome Therapeutics
AXSM
$10.9B
$19.6M 0.1%
+272,800
New +$20.1M
SEDA
72
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$18.1M 0.09%
1,732,500
BHVN icon
73
Biohaven
BHVN
$2.21B
$17.9M 0.09%
750,000
ZYME icon
74
Zymeworks
ZYME
$1.73B
$17.3M 0.09%
2,000,000
AAC
75
DELISTED
Ares Acquisition Corporation
AAC
$15.1M 0.08%
1,425,000

Similar funds

Farallon Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Farallon Capital Management held 208 positions worth $19.9B, up 8.8% from $18.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Farallon Capital Management's Q2 2023 filing shows 17 new, 41 increased, 35 reduced and 35 closed positions. Its largest new stake was Analog Devices: 2,075,000 shares worth $404M. The largest sale was Shaw Communications Inc., an estimated $473M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q2 2023 buy was Analog Devices: 2,075,000 shares worth $404M.
  • Farallon Capital Management added most to VMware, Inc in Q2 2023, an estimated $286M increase.
  • Farallon Capital Management's biggest Q2 2023 reduction was Salesforce, cutting an estimated $318M.
  • Farallon Capital Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $473M.
  • Farallon Capital Management's ten largest holdings make up 44% of its $19.9B portfolio in Q2 2023.
  • Farallon Capital Management opened 17 new positions and closed 35 in Q2 2023.
  • Farallon Capital Management's portfolio value rose 8.8% quarter-over-quarter to $19.9B.

Based on Farallon Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.